Evidence map›Paper›PMID 39828097›Full record

ArticleThe Journal of biological chemistry2025

Metabolic dysfunction in mice with adipocyte-specific ablation of the adenosine A2A receptor.

Narendra Verma, Luce Perie, Michele Silvestro, Anupama Verma, Bruce N Cronstein, Bhama Ramkhelawon, Elisabetta Mueller

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Narendra VermaHolman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA; Department of Systems Biology, Center of Biomedical Research, SGPGI campus, Lucknow, India.
Luce PerieHolman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Michele SilvestroDivision of Vascular and Endovascular Surgery, Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Anupama VermaHolman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Bruce N CronsteinDivision of Translational Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Bhama RamkhelawonDivision of Vascular and Endovascular Surgery, Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Elisabetta MuellerHolman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA. Electronic address: Elisabetta.Mueller@nyumc.org.

Funding

Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL, HOCHMAN, JUDITH S · 2012 to 2014
$16.8M
Novel mechanisms regulating adipose tissue function in health and diseaseR01DK133377 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Elisabetta Mueller · 2023 to 2026
$1.9M
The zinc finger protein ZNF638 is a novel transcriptional regulator of thermogenesis - ResubmissionR01DK116845 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MUELLER, ELISABETTA · 2019 to 2022
$1.7M
NCATS NIH HHS UL1 TR000038NIDDK NIH HHS R01 DK116845NIDDK NIH HHS R01 DK133377
6 · The paper itself

Abstract

It has been well established that adenosine plays a key role in the control of inflammation through G protein coupled receptors and recently shown that it can regulate thermogenesis. Here we investigated the specific requirements of the adenosine A2A receptor (A2AR) in mature adipocytes for thermogenic functionality and metabolic homeostasis. We generated fat tissue-specific adenosine A2AR KO mice to assess the influence of signaling through this receptor on brown and beige fat functionality, obesity, insulin sensitivity, inflammation, and liver function. Fat-specific A2AR KO and WT littermate mice were compared for potential differences in cold tolerance and energy metabolism. In addition, we measured glucose metabolism, AT inflammation, and liver phenotypes in mice of the two genotypes after exposure to a diet rich in fat. Our results provide novel evidence indicating that loss of the adenosine A2AR specifically in adipocytes is associated with cold intolerance and decreased oxygen consumption. Furthermore, mice with fat specific ablation of the A2AR exposed to a diet rich in fat showed increased propensity to obesity, decreased insulin sensitivity, elevated adipose tissue inflammation, and hepato-steatosis and hepato-steatitis. Overall, our data provide novel evidence that A2AR in mature adipocytes safeguards metabolic homeostasis, suggesting the possibility of targeting this receptor selectively in fat for the treatment of metabolic disease.

Indexed as

AdipocytesReceptor, Adenosine A2AAnimalsEnergy MetabolismFatty LiverInflammationInsulin ResistanceLiverMaleMiceMice, Inbred C57BLMice, KnockoutObesityThermogenesisAdora2a protein, mouseReceptor, Adenosine A2Aadenosine A2A receptorbrown and beige adipose tissueinsulin resistanceobesityUCP1

Identifiers

PMID39828097
PMCPMC11850162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.